Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Bifidobacterium animalis subsp. lactis BB-12 and Improved Gastrointestinal Health

Research synthesisLow evidenceMixed effect size3 studies · 3 beneficial · 0 neutral · 0 harmful

Across 3 review studies, all reported beneficial effects of Bifidobacterium animalis subsp. lactis BB-12 on gastrointestinal health. Effect sizes were mixed (small to large) across the studies. Doses and populations were not consistently reported.

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. Available evidence is overwhelmingly positive, but clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). None of the included studies reported statistically significant findings, and all are review articles rather than original trials, limiting the strength of conclusions.

Generated Jul 12, 2026
3 of 3 papers
Back to top